InspireMD Net Receivables from 2010 to 2025

NSPR Stock  USD 2.44  0.07  2.79%   
InspireMD Net Receivables yearly trend continues to be relatively stable with very little volatility. Net Receivables is likely to drop to about 1.4 M. During the period from 2010 to 2025, InspireMD Net Receivables destribution of quarterly values had range of 1.7 M from its regression line and mean deviation of  481,662. View All Fundamentals
 
Net Receivables  
First Reported
2011-03-31
Previous Quarter
2.3 M
Current Value
1.6 M
Quarterly Volatility
597.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check InspireMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InspireMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 194.1 K, Interest Expense of 23.9 K or Selling General Administrative of 8.6 M, as well as many indicators such as Price To Sales Ratio of 14.95, Dividend Yield of 0.0 or PTB Ratio of 3.21. InspireMD financial statements analysis is a perfect complement when working with InspireMD Valuation or Volatility modules.
  
Build AI portfolio with InspireMD Stock
Check out the analysis of InspireMD Correlation against competitors.
To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

Latest InspireMD's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of InspireMD over the last few years. It is InspireMD's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InspireMD's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Very volatile
   Net Receivables   
       Timeline  

InspireMD Net Receivables Regression Statistics

Arithmetic Mean1,296,922
Geometric Mean1,177,743
Coefficient Of Variation43.86
Mean Deviation481,662
Median1,247,000
Standard Deviation568,804
Sample Variance323.5B
Range1.7M
R-Value0.09
Mean Square Error343.8B
R-Squared0.01
Significance0.74
Slope10,834
Total Sum of Squares4.9T

InspireMD Net Receivables History

20251.4 M
20242.3 M
20231.8 M
20221.2 M
20211.4 M
2020945 K
2019973 K

About InspireMD Financial Statements

InspireMD shareholders use historical fundamental indicators, such as Net Receivables, to determine how well the company is positioned to perform in the future. Although InspireMD investors may analyze each financial statement separately, they are all interrelated. The changes in InspireMD's assets and liabilities, for example, are also reflected in the revenues and expenses on on InspireMD's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables2.3 M1.4 M

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.